Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RORC | P51449 | 15/20 | 0.52 |
| ▸ | HTR6 | P50406 | 3/20 | 0.47 |
| ▸ | PKM | P14618 | 1/20 | 0.46 |
| ▸ | PKLR | P30613 | 1/20 | 0.46 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.42 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.42 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.42 |
| ▸ | RORA | P35398 | 1/20 | 0.42 |
| ▸ | RORB | Q92753 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24286803 | 0.93 | RORC (0.49) | RORCHTR6PKMPKLRNR1I2 | |
| SCHEMBL24286437 | 0.89 | RORC (0.69) | RORCNR1I2RORARORB | |
| SCHEMBL24286226 | 0.88 | RORC (0.51) | RORCHTR6PKMPKLRCYP11B1 | |
| SCHEMBL24286434 | 0.88 | RORC (0.55) | RORCHTR6PKMPKLRNR1I2 | |
| SCHEMBL24286807 | 0.88 | RORC (0.60) | RORCNR1I2RORARORB | |
| SCHEMBL24286552 | 0.87 | RORC (0.44) | RORCHTR6PKMPKLRCYP11B1 | |
| SCHEMBL24286445 | 0.87 | RORC (0.54) | RORCHTR6PKMPKLRCYP11B1 | |
| SCHEMBL24286280 | 0.86 | PKM (0.43) | RORCHTR6PKMPKLRCYP11B1 | |
| SCHEMBL18312995 | 0.86 | RORC (0.62) | RORCPKMPKLRNR1I2RORA | |
| SCHEMBL24287052 | 0.86 | RORC (0.49) | RORCHTR6PKMPKLRNR1I2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3307738-B1 | ARYL DIHYDRO-2H-BENZO[B][1,4]OXAZINE SULFONAMIDE AND RELATED COMPOUNDS FOR USE AS AGONISTS OF RORY AND THE TREATMENT OF DISEASE | UNIV MICHIGAN REGENTS (US) | 2022-04-20 | — | — | EP | disclosed |